Neurocognition as a predictor of transition to psychotic disorder and functional outcomes in ultra-high risk participants: Findings from the NEURAPRO randomized clinical trial
Version 2 2024-06-05, 11:19Version 2 2024-06-05, 11:19
Version 1 2021-05-10, 16:06Version 1 2021-05-10, 16:06
journal contribution
posted on 2024-06-05, 11:19authored byLK Bolt, GP Amminger, J Farhall, PD McGorry, B Nelson, C Markulev, HP Yuen, MR Schäfer, N Mossaheb, M Schlögelhofer, S Smesny, IB Hickie, GE Berger, EYH Chen, L de Haan, DH Nieman, M Nordentoft, A Riecher-Rössler, S Verma, A Thompson, Alison YungAlison Yung, KA Allott
Neurocognition as a predictor of transition to psychotic disorder and functional outcomes in ultra-high risk participants: Findings from the NEURAPRO randomized clinical trial